Clinical Trial Update: Efficacy of Probaclac in Irritable Bowel Syndrome in Children Aged 8 to 18 Years [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Probaclac for pediatric irritable bowel syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Probaclac

Snippet

Sponsor: St. Justine's Hospital | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: TERMINATED